Patients should be the tipping point of individualizing breast cancer surgery: Commentary on 'Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges'

J Heil¹, A Pfob²

Affiliations

¹ Department of Gynecology, Heidelberg University, Heidelberg, Germany. Electronic address: joerg.heil@med.uni-heidelberg.de.
² Department of Gynecology, Heidelberg University, Heidelberg, Germany.

Free article

Comment

J Heil et al. Ann Oncol. 2020 Sep.

Free article

. 2020 Sep;31(9):1264.

doi: 10.1016/j.annonc.2020.05.021. Epub 2020 May 28.

J Heil¹, A Pfob²

¹ Department of Gynecology, Heidelberg University, Heidelberg, Germany. Electronic address: joerg.heil@med.uni-heidelberg.de.
² Department of Gynecology, Heidelberg University, Heidelberg, Germany.

No abstract available

Conflict of interest statement

Disclosures The authors have nothing to disclose.

Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges.
Heil J, Kuerer HM, Pfob A, Rauch G, Sinn HP, Golatta M, Liefers GJ, Vrancken Peeters MJ. Heil J, et al. Ann Oncol. 2020 Jan;31(1):61-71. doi: 10.1016/j.annonc.2019.10.012. Ann Oncol. 2020. PMID: 31912797 Review.
Important considerations prior to elimination of breast cancer surgery after neoadjuvant systemic therapy: Listening to what our patients want.
Caballero C, Piccart M. Caballero C, et al. Ann Oncol. 2020 Aug;31(8):1083-1084. doi: 10.1016/j.annonc.2020.04.009. Epub 2020 Apr 25. Ann Oncol. 2020. PMID: 32344012 No abstract available.